Search - tctmd.com

Displaying 181 - 200 of 403

Sort: Relevancy | Date

Presentation TCT 2022

TCT 104: Impact of Left Ventricular Ejection Fraction (EF) on 10-year Mortality after Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Grafting (CABG) : Is CABG Safer Than PCI in all Patients With Reduced Ejection Fraction (rEF) ?

Presenter: Patrick Serruys

September 18, 2022

Presentation TCT 2022

TCT 103: Impact of pre-existing and new atrial fibrillation on major adverse cardiac events following coronary revascularization

Presenter: Omar Abdel-Razek

September 18, 2022

Presentation TCT 2022

TCT 342: Early Multi-center Clinical Outcomes of a No-Implant Interatrial Shunt for Heart Failure with Preserved and Reduced Ejection Fraction: Latest Results From the Early Feasibility ALLEVIATE-HF Programs

Presenter: Roxana Mehran

September 18, 2022

Presentation TCT 2022

TCT 101: Machine learning-based prediction of long-term mortality following percutaneous and surgical revascularisation in patients with complex coronary artery disease: analysis of the multicentre randomised controlled SYNTAXES trial with external…

Presenter: Patrick Serruys

September 18, 2022

Presentation TCT 2022

TCT 341: Intermittent Occlusion of the Superior Vena Cava Reduces Estimated Stressed Blood Volume in Patients with Acutely Decompensated Heart Failure

Presenter: Michael Kiernan

September 18, 2022

News Conference News TCT 2022

Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI

Yael L. Maxwell

September 18, 2022

Presentation TCT 2022

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

Presenter: Tanesh Ayyalu

September 18, 2022

Presentation TCT 2022

TCT 340: Intermittent Occlusion of the Superior Vena Cava Improves Urine Sodium Excretion in Patients with Acutely Decompensated Heart Failure

Presenter: Rayan Yousefzai

September 18, 2022

Presentation TCT 2022

TCT 133: Efficacy and Safety of Drug-coated Balloons According to Coronary Vessel Size. A Report from the BASKET-SMALL 2 Trial

Presenter: Bruno Scheller

September 18, 2022

Presentation TCT 2022

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

Presenter: Mijin Kim

September 18, 2022

Presentation TCT 2022

TCT 132: In Vitro Benchtop Assessment of Particulate Generation from Drug-coated Balloons

Presenter: Hui Ying Ang

September 18, 2022

Presentation TCT 2022

TCT 327: Clinical and Radiographic Measures of Stroke-Related Outcomes with Cerebral Embolic Protection Devices During TAVR: A Meta-analysis.

Presenter: Arpanjeet Kaur

September 18, 2022

Presentation TCT 2022

TCT 338: Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Andrea Scotti

September 18, 2022

Presentation TCT 2022

TCT 131: Impact of Scoring Balloons on Drug Absorption Prior to Drug-coated Balloon Deployment- a Cadaver-based Study

Presenter: John Shulze

September 18, 2022

Presentation TCT 2022

TCT 189: The efficacy and safety of an adjunctive transcoronary pacing strategy during rotational atherectomy: The results of the Strategy to ROTAblate and PACE (ROTA-PACE) study.

Presenter: M Bilal Iqbal

September 18, 2022

Presentation TCT 2022

TCT 130: Drug-Coated Balloons for the Treatment of Small Vessel Coronary Artery Disease: Primary Outcomes of a Multicenter Randomized Non-Inferiority Trial

Presenter: Paul Underwood

September 18, 2022

Presentation TCT 2022

TCT 336: Eligibility to Coapt Trial in the Daily Practice: a Real-World Experience

Presenter: edoardo zancanaro

September 18, 2022

News Conference News TCT 2022

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

Todd Neale

September 18, 2022

Presentation TCT 2022

TCT 187: Safety of Orbital Atherectomy in Patients With and Without Aortic Stenosis

Presenter: Karthik Vedantam

September 18, 2022

Presentation TCT 2022

TCT 335: Mitral Regurgitation Severity to Left Atrial Volume Ratio in Heart Failure Patients with Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Andrea Scotti

September 18, 2022

Advertisement

TCT 104: Impact of Left Ventricular Ejection Fraction (EF) on 10-year Mortality after Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Grafting (CABG) : Is CABG Safer Than PCI in all Patients With Reduced Ejection Fraction (rEF) ?

TCT 103: Impact of pre-existing and new atrial fibrillation on major adverse cardiac events following coronary revascularization

TCT 342: Early Multi-center Clinical Outcomes of a No-Implant Interatrial Shunt for Heart Failure with Preserved and Reduced Ejection Fraction: Latest Results From the Early Feasibility ALLEVIATE-HF Programs

TCT 101: Machine learning-based prediction of long-term mortality following percutaneous and surgical revascularisation in patients with complex coronary artery disease: analysis of the multicentre randomised controlled SYNTAXES trial with external…

TCT 341: Intermittent Occlusion of the Superior Vena Cava Reduces Estimated Stressed Blood Volume in Patients with Acutely Decompensated Heart Failure

Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

TCT 340: Intermittent Occlusion of the Superior Vena Cava Improves Urine Sodium Excretion in Patients with Acutely Decompensated Heart Failure

TCT 133: Efficacy and Safety of Drug-coated Balloons According to Coronary Vessel Size. A Report from the BASKET-SMALL 2 Trial

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

TCT 132: In Vitro Benchtop Assessment of Particulate Generation from Drug-coated Balloons

TCT 327: Clinical and Radiographic Measures of Stroke-Related Outcomes with Cerebral Embolic Protection Devices During TAVR: A Meta-analysis.

TCT 338: Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

TCT 131: Impact of Scoring Balloons on Drug Absorption Prior to Drug-coated Balloon Deployment- a Cadaver-based Study

TCT 189: The efficacy and safety of an adjunctive transcoronary pacing strategy during rotational atherectomy: The results of the Strategy to ROTAblate and PACE (ROTA-PACE) study.

TCT 130: Drug-Coated Balloons for the Treatment of Small Vessel Coronary Artery Disease: Primary Outcomes of a Multicenter Randomized Non-Inferiority Trial

TCT 336: Eligibility to Coapt Trial in the Daily Practice: a Real-World Experience

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

TCT 187: Safety of Orbital Atherectomy in Patients With and Without Aortic Stenosis

TCT 335: Mitral Regurgitation Severity to Left Atrial Volume Ratio in Heart Failure Patients with Secondary Mitral Regurgitation: The COAPT Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content